HUP9700632A3 - Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same - Google Patents

Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same

Info

Publication number
HUP9700632A3
HUP9700632A3 HU9700632A HUP9700632A HUP9700632A3 HU P9700632 A3 HUP9700632 A3 HU P9700632A3 HU 9700632 A HU9700632 A HU 9700632A HU P9700632 A HUP9700632 A HU P9700632A HU P9700632 A3 HUP9700632 A3 HU P9700632A3
Authority
HU
Hungary
Prior art keywords
cyclodextrine
producing
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9700632A
Other languages
Hungarian (hu)
Original Assignee
Cyclolab Ciklodextrin Kutato F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclolab Ciklodextrin Kutato F filed Critical Cyclolab Ciklodextrin Kutato F
Priority to HU9700632A priority Critical patent/HUP9700632A3/en
Publication of HU9700632D0 publication Critical patent/HU9700632D0/en
Priority to PCT/HU1998/000028 priority patent/WO1998042382A1/en
Priority to AU68481/98A priority patent/AU6848198A/en
Priority to EP98913968A priority patent/EP0969874A1/en
Priority to JP54325498A priority patent/JP2002514210A/en
Priority to ZA982457A priority patent/ZA982457B/en
Priority to HRP9700632A priority patent/HRP980155A2/en
Priority to ARP980101328A priority patent/AR010910A1/en
Publication of HUP9700632A2 publication Critical patent/HUP9700632A2/en
Publication of HUP9700632A3 publication Critical patent/HUP9700632A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
HU9700632A 1997-03-24 1997-03-24 Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same HUP9700632A3 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
HU9700632A HUP9700632A3 (en) 1997-03-24 1997-03-24 Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
PCT/HU1998/000028 WO1998042382A1 (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
AU68481/98A AU6848198A (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
EP98913968A EP0969874A1 (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
JP54325498A JP2002514210A (en) 1997-03-24 1998-03-23 Pharmaceutical composition containing propaneamine derivative and cyclodextrin
ZA982457A ZA982457B (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin
HRP9700632A HRP980155A2 (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin
ARP980101328A AR010910A1 (en) 1997-03-24 1998-03-24 PHARMACEUTICAL COMPOSITIONS CONTAINING PROPANAMINE AND CYCLODEXTRIN DERIVATIVES, THE INCLUSION COMPLEXES THAT MAKE THEM, A PROCEDURE FOR THE PREPARATION OF THESE LASTS, AND A METHOD OF ANTI-DEPRESSIVE TREATMENT USING THE PHARMACEUTICAL COMPOSITIONS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700632A HUP9700632A3 (en) 1997-03-24 1997-03-24 Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same

Publications (3)

Publication Number Publication Date
HU9700632D0 HU9700632D0 (en) 1997-05-28
HUP9700632A2 HUP9700632A2 (en) 1998-12-28
HUP9700632A3 true HUP9700632A3 (en) 1999-10-28

Family

ID=89994898

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700632A HUP9700632A3 (en) 1997-03-24 1997-03-24 Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same

Country Status (8)

Country Link
EP (1) EP0969874A1 (en)
JP (1) JP2002514210A (en)
AR (1) AR010910A1 (en)
AU (1) AU6848198A (en)
HR (1) HRP980155A2 (en)
HU (1) HUP9700632A3 (en)
WO (1) WO1998042382A1 (en)
ZA (1) ZA982457B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091192B1 (en) * 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
EP1109806B8 (en) * 1999-07-01 2003-10-29 Italfarmaco S.p.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
KR20140070676A (en) 2002-09-06 2014-06-10 인설트 테라페틱스, 인코퍼레이티드 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
WO2004069187A2 (en) * 2003-02-03 2004-08-19 Shire Laboratories, Inc. Drug formulation and delivery using crystalline methylated cyclodextrins
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
AU2017259576B2 (en) * 2016-05-06 2020-09-17 Biodynamic Research Foundation Polymerized drug-containing pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
WO1991013100A1 (en) * 1990-03-02 1991-09-05 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications

Also Published As

Publication number Publication date
HRP980155A2 (en) 1998-12-31
ZA982457B (en) 1998-09-23
AU6848198A (en) 1998-10-20
HU9700632D0 (en) 1997-05-28
HUP9700632A2 (en) 1998-12-28
AR010910A1 (en) 2000-07-12
WO1998042382A1 (en) 1998-10-01
JP2002514210A (en) 2002-05-14
EP0969874A1 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
HUP0001802A3 (en) Pyrazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0100723A3 (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004334A2 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for producing them and pharmaceutical compositions containing them
IL131298A0 (en) A pharmaceutical composition and a process for producing the same
HUP9802653A3 (en) Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
HUP0001522A3 (en) Benzoimidazole derivatives, process for producing them and pharmaceutical compositions containing them
HU9802180D0 (en) Process for producing pharmaceutical compositions
HUP0003614A3 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
EP0990632A4 (en) Adamantanemethanol derivatives and process for the preparation thereof
HU9503801D0 (en) Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them
HUP0001827A3 (en) Colchicine derivatives, process for producing them, pharmaceutical compositions containing them, and use thereof for producing pharmaceutical compositions
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
HUP0100785A3 (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700632A3 (en) Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
HUP0004294A3 (en) Indole derivatives, pharmaceutical compositions containing them and process for producing them
HUP0003766A2 (en) Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004457A3 (en) Angiogenesis inhibiting thiadiazolyl-pyridazine derivatives, process for producing them and pharmaceutical compositions containing the same
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003997A3 (en) 3-benzylpiperidine derivatives, pharmaceutical compositions containing them and process for producing them
HUP0004177A3 (en) 4,5-diaryloxazole derivatives, pharmaceutical compositions containing them and process for producing them